Facial Pyoderma Gangrenosum – Presentation of Two Clinical Cases and Literature Review

Małgorzata N. Grabarczyk; Kamila Zawadzińska-Halat; Jolanta Smyk; Maciej Pastuszczak

doi:10.5114/dr.2024.150242

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

6/2024
vol. 111

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

Facial Pyoderma Gangrenosum – Presentation of Two Clinical Cases and Literature Review

Małgorzata N. Grabarczyk

¹

,

Kamila Zawadzińska-Halat

^{1, 2}

,

Jolanta Smyk

¹

,

Maciej Pastuszczak

^{1, 2}

Department of Internal Medicine, Dermatology and Allergology, the Specialist Hospital, Zabrze, Poland
Department of Dermatology in Zabrze, Silesian Medical University in Katowice, Poland

Dermatol Rev/Przegl Dermatol 2024, 111, 429-434

DOI: https://doi.org/10.5114/dr.2024.150242

Data publikacji online: 2025/05/21

Pełna treść artykułu Pobierz cytowanie

Metryki PlumX:

Pyoderma gangrenosum is a rare neutrophilic dermatosis characterized by a distinct clinical course and typical morphology of skin lesions. Most commonly, it affects the lower legs, while head and neck involvement is extremely rare. We present 2 cases of pyoderma gangrenosum manifesting on the face, with simultaneous exacerbation of inflammatory bowel disease. In the treatment regimen, anti-TNF-a inhibitors were administered alongside steroid therapy, leading to rapid remission of the skin lesions. Treatment with infliximab was associated with rapid remission of pyoderma gangrenosum and a reduction in the severity of the inflammatory process in the gastrointestinal tract. Infliximab is a highly effective option for managing facial pyoderma gangrenosum in patients with coexisting inflammatory bowel disease and should be considered as the first-line treatment. In the differential diagnosis of non-healing facial ulcers, pyoderma gangrenosum should be considered alongside neoplasms and granulomatosis with polyangiitis, particularly when the patient’s medical history suggests bowel disease.

Indeks osobowy

Facial Pyoderma Gangrenosum – Presentation of Two Clinical Cases and Literature Review

Małgorzata N. Grabarczyk 1 , Kamila Zawadzińska-Halat 1, 2 , Jolanta Smyk 1 , Maciej Pastuszczak 1, 2

Małgorzata N. Grabarczyk

¹

,

Kamila Zawadzińska-Halat

^{1, 2}

,

Jolanta Smyk

¹

,

Maciej Pastuszczak

^{1, 2}